Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • In Brief
  • Published:

Diabetes

Outcomes associated with nonalbuminuric CKD

Nature Reviews Nephrology volume 11, page 630 (2015)Cite this article

Subjects

Nonalbuminuric chronic kidney disease (CKD) is not a frequent finding in patients with type 1 diabetes mellitus (T1DM) but is associated with cardiovascular morbidity and all-cause mortality, according to new research. In an observational study of 3,809 patients with T1DM, 78 (2.0%) patients had nonalbuminuric CKD at baseline. After a median follow-up of 13 years, these patients had an increased risk of cardiovascular events and all-cause mortality but were not at increased risk of albuminuria or end-stage renal disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Thorn, L. M. et al. The presence and consequence of nonalbuminuric chronic kidney disease in patients with type 1 diabetes. Diabetes Care 10.2337/dc15-0641

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Outcomes associated with nonalbuminuric CKD. Nat Rev Nephrol 11, 630 (2015). https://doi.org/10.1038/nrneph.2015.156

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrneph.2015.156

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing